Status:
COMPLETED
Clinical Performance of NIPT in Multiple Gestation Pregnancies
Lead Sponsor:
University of Pennsylvania
Collaborating Sponsors:
Sequenom, Inc/Laboratory Corporation of America Holdings
Conditions:
Trisomy 21 in Fetus
Eligibility:
FEMALE
18+ years
Brief Summary
This study plans to evaluate the clinical performance of the MaterniT21 PLUS and/or GENOME Laboratory Developed Test, in the detection of fetal trisomy 21 in circulating cell-free DNA extracted from m...
Eligibility Criteria
Inclusion
- subject pregnant with a multiple gestation and received NIPT from Sequenom Laboratories;
- subject was 18 or older at the time of NIPT
Exclusion
- none
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 19 2022
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04488393
Start Date
March 1 2020
End Date
June 19 2022
Last Update
December 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104